Dr. Rajeev Soni

Genei Laboratories, India

Title: Impact of COVID-19 Worldwide and its Prevention



The COVID-19 disease caused by the SARS-CoV-2 virus has created havoc around the world, leading to more than 5 million deaths globally and bringing down economies to a standstill. It’s been two years since the origin of COVID-19 in China and the entire world is still grappling with the disease, despite concerted efforts with regards to emergency use of vaccination and adherence to COVID norms of wearing masks in public, physical/social distancing, washing hands frequently, avoiding crowded places, and being in places with adequate ventilation as measures to control the deadly disease. According to estimates by IHME, increase in vaccine uptake and wearing of masks have been the key to preventing COVID 19 transmission and eventually death. The death rate due to COVID 19, in the year 2021 so far, among majority of the countries around the world has been around 0.2%-0.3% of the total population, except China where there is no significant mortality(death rate of 0.0003%), though the absolute numbers vary. Adaptation of increased vaccination leading to double dosed population, and continuing of wearing masks would not only lead to a further reduction in the number of COVID-19 cases going forward, but also lessen disease severity and eventually death, for those who contract the disease. Wearing masks and getting double vaccinated is thus a key recommendation along with following of other COVID-19 norms as mentioned above, for all the countries in the world in order to reduce and prevent the incidence of the disease.


Dr. Rajeev Soni is presently working as Head, Technical Operations at Genei Laboratories, Bengaluru, India. Earlier he has worked for multi-national companies such as Biomereiux, Novozymes and Novartis. Did his Ph.D. in Molecular Biology and Biotechnology from the University of Cambridge, U.K., has more than 25 years of experience in industry and academia, both nationally and internationally. His specialization includes drug discovery research(cancer and infectious disease), molecular diagnostics based on Real-time PCR and enzyme engineering. To his credit, he has published more than 20 articles in various international peer reviewed journals and is a holder of 5 patents.

Follow Us